Indivior Pharmaceuticals (INDV) Accumulated Expenses (2023 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Accumulated Expenses of $14.0 million for Q1 2026, down 86.67% year-over-year from $105.0 million in Q1 2025, and down 66.67% quarter-over-quarter from $42.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Accumulated Expenses (2023 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 86.67% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $14.0 million (down 86.67% YoY), while the FY2025 annual figure was $42.0 million, down 57.58% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $14.0 million, down from $42.0 million in the prior quarter.
- The five-year high for Accumulated Expenses was $492.0 million in Q4 2023, with the low at $14.0 million in Q1 2026.
- The 4-year median for Accumulated Expenses is $105.0 million (2025), against an average of $137.6 million.
- The sharpest annual moves came in 2025 and 2026: Accumulated Expenses tumbled 57.58% in 2025, then plunged 86.67% in 2026.
- Indivior Pharmaceuticals' Accumulated Expenses stood at $492.0 million in 2023, then slumped by 79.88% to $99.0 million in 2024, then sank by 57.58% to $42.0 million in 2025, then slumped by 66.67% to $14.0 million in 2026.
- Business Quant data shows INDV's Accumulated Expenses at $14.0 million in Q1 2026, $42.0 million in Q4 2025, and $106.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 42.00 Mn |
| Sep 30, 2025 | 106.00 Mn |
| Jun 30, 2025 | 105.00 Mn |
| Mar 31, 2025 | 105.00 Mn |
| Dec 31, 2024 | 99.00 Mn |
| Dec 31, 2023 | 492.00 Mn |